Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind Trial to Study the Effects of Etidronate on Ectopic CALCIfication in FAhr's Disease or Syndrome

NCT05662111 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05662111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05662111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind Trial to Study the Effects of Etidronate on Ectopic CALCIfication in FAhr's Disease or Syndrome
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Recruiting
Start date
April 3, 2023
Completion date
December 31, 2027
Enrollment
98 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fahr disease, fahr syndrome, primary familial brain calcification